These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35480282)

  • 41. Possible New Strategies for the Treatment of Congenital Hyperinsulinism.
    Sikimic J; Hoffmeister T; Gresch A; Kaiser J; Barthlen W; Wolke C; Wieland I; Lendeckel U; Krippeit-Drews P; Düfer M; Drews G
    Front Endocrinol (Lausanne); 2020; 11():545638. PubMed ID: 33193079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
    Li H; Zhao JL; Zhang YM; Han SX
    Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells.
    Ruggieri P; Mangino G; Fioretti B; Catacuzzeno L; Puca R; Ponti D; Miscusi M; Franciolini F; Ragona G; Calogero A
    PLoS One; 2012; 7(10):e47825. PubMed ID: 23110108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. K
    Bulk E; Kramko N; Liashkovich I; Glaser F; Schillers H; Schnittler HJ; Oberleithner H; Schwab A
    Oncotarget; 2017 Dec; 8(68):112268-112282. PubMed ID: 29348824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
    Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
    Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The combined activation of K
    Pillozzi S; D'Amico M; Bartoli G; Gasparoli L; Petroni G; Crociani O; Marzo T; Guerriero A; Messori L; Severi M; Udisti R; Wulff H; Chandy KG; Becchetti A; Arcangeli A
    Br J Cancer; 2018 Jan; 118(2):200-212. PubMed ID: 29161243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
    Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
    Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
    Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R
    Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel.
    Huang C; Pollock CA; Chen XM
    PLoS One; 2014; 9(4):e95173. PubMed ID: 24733189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke.
    Yi M; Wei T; Wang Y; Lu Q; Chen G; Gao X; Geller HM; Chen H; Yu Z
    J Neuroinflammation; 2017 Oct; 14(1):203. PubMed ID: 29037241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The calcium-activated potassium channel KCa3.1 plays a central role in the chemotactic response of mammalian neutrophils.
    Henríquez C; Riquelme TT; Vera D; Julio-Kalajzić F; Ehrenfeld P; Melvin JE; Figueroa CD; Sarmiento J; Flores CA
    Acta Physiol (Oxf); 2016 Jan; 216(1):132-45. PubMed ID: 26138196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells.
    Chimote AA; Hajdu P; Kucher V; Boiko N; Kuras Z; Szilagyi O; Yun YH; Conforti L
    J Immunol; 2013 Dec; 191(12):6273-80. PubMed ID: 24227782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.
    Zeglis BM; Pillarsetty N; Divilov V; Blasberg RA; Lewis JS
    Nucl Med Biol; 2011 Jul; 38(5):683-96. PubMed ID: 21718944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One-step
    Zhao X; Lv G; Li K; Peng Y; Liu Q; Qiu L; Lin J
    Nucl Med Biol; 2020; 82-83():72-79. PubMed ID: 32109829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
    Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
    Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of protein kinase A and class II phosphatidylinositol 3-kinase C2β in the downregulation of KCa3.1 channel synthesis and membrane surface expression by lyso-globotriaosylceramide.
    Choi JY; Park S
    Biochem Biophys Res Commun; 2016 Feb; 470(4):907-12. PubMed ID: 26820527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular dynamics simulations of scorpion toxin recognition by the Ca(2+)-activated potassium channel KCa3.1.
    Chen R; Chung SH
    Biophys J; 2013 Oct; 105(8):1829-37. PubMed ID: 24138859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
    Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
    J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
    Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
    Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ca
    Yu Z; Dou F; Wang Y; Hou L; Chen H
    J Neuroinflammation; 2018 Nov; 15(1):316. PubMed ID: 30442153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.